ACE, ARB Slow Retinopathy but Not Nephropathy in Type 1 Diabetes Type 1 diabetes patients who start on renin-angiotensin blockers early may slow development of retinopathy by up to 70%, a clinical trial revealed. But neither an angiotensin-receptor blocker (ARB) nor an ACE inhibitor significantly slowed progression of nephropathy over five years by any measure, Michael Mauer, MD, of the University of Minnesota in Minneapolis, and colleagues [...]
Source: feedproxy.google.comStamina-Rx Dietary Supplement Products FDA and Hi-Tech Pharmaceuticals notified patients and healthcare professionals of a nationwide recall of all product sold under the name Stamina-Rx. Hi-Tech was notified by the
FDA that the lab analysis of Stamina-Rx samples found that the product contained the undeclared ingredient − benzamidenafil − a Phosphodiesterase Type 5 inhibitor.
Source: www.fda.gov
# posted by Network @ 11:26 AM
